by Darrin Disley | Jul 9, 2026 | Uncategorized
9th July 2026 Cardiogeni PLC (“Cardiogeni”, “CGNI” or the “Company”) Grant of Incentive Options over Stock Cardiogeni (AQSE: CGNI), a UK clinical stage biotechnology company founded by 2007 Nobel Laureate Sir Martin Evans to develop and...
by Darrin Disley | Jun 29, 2026 | Uncategorized
29th June 2026 Cardiogeni PLC (“Cardiogeni”, “CGNI” or the “Company”) Grant of Incentive Options over Stock Cardiogeni (AQSE: CGNI), a UK clinical stage biotechnology company founded by 2007 Nobel Laureate Sir Martin Evans to develop and...
by Darrin Disley | May 26, 2026 | Uncategorized
26th May 2026 Cardiogeni PLC (“Cardiogeni”, “CGNI” or the “Company”) Repayment of Convertible Loan Notes Cardiogeni (AQSE: CGNI), a UK clinical stage biotechnology company founded by 2007 Nobel Laureate Sir Martin Evans to develop and...
by Darrin Disley | Apr 29, 2026 | Uncategorized
Cardiogeni PLC (“Cardiogeni”, “CGNI” or the “Company”) Update on Share Exchange Agreement with Kira Health Invest AG Cardiogeni (AQSE: CGNI), a UK clinical stage biotechnology company founded by 2007 Nobel Laureate Sir Martin Evans...
by Darrin Disley | Apr 21, 2026 | Uncategorized
Cardiogeni PLC (“Cardiogeni”, “CGNI” or the “Company”) Completion of Share Exchange Agreement with Kira Health Invest AG and Issuance of Equity Cardiogeni (AQSE: CGNI), a UK clinical stage biotechnology company founded by 2007 Nobel Laureate...
